Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2011 · 10-Q
Revenue$2.93B$2.93B+11.6% vs Q3 2010 Net Income$265.40M$265.40M−1.2% vs Q3 2010 EPS Diluted$0.69$0.69+4.5% vs Q3 2010 Gross Profit$1,218,900,000+14.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$360,700,000−16.7% Free Cash Flowderived$297,900,000−19.4% Margins · derivedGross margin41.6%+1.2 pt vs Q3 2010
Operating margin10.8%−0.7 pt vs Q3 2010
Net margin9.0%−1.2 pt vs Q3 2010
ended Oct 1, 2011 · filed Nov 4, 2011 · 34 d after period end